Race Oncology (ASX:RAC) Other Long Term Assets : A$-0.00 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Race Oncology Other Long Term Assets?

Race Oncology's other long-term assets for the quarter that ended in Dec. 2024 was A$-0.00 Mil.

Race Oncology's quarterly other long-term assets increased from Dec. 2023 (A$-0.00 Mil) to Jun. 2024 (A$-0.00 Mil) and increased from Jun. 2024 (A$-0.00 Mil) to Dec. 2024 (A$-0.00 Mil).

Race Oncology's annual other long-term assets declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil) and declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$-0.00 Mil).

Race Oncology Other Long Term Assets Historical Data

The historical data trend for Race Oncology's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology Other Long Term Assets Chart

Race Oncology Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long Term Assets

Get a 7-Day Free Trial

Race Oncology Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial												-	-	-	-	-

Race Oncology Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Race Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (ASX:RAC) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000

Website

https://www.raceoncology.com

Race Oncology Ltd is a clinical stage biopharmaceutical company with a mission to be at the heart of cancer care. Its asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a clinical history with demonstrated therapeutic benefits in both adult and pediatric patients, a well-characterized safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. It has reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where Race can deliver cardioprotection and enhanced anticancer activity in solid tumors.

Race Oncology Headlines

No Headlines